Zobrazeno 1 - 10
of 75
pro vyhledávání: '"Peter, Jirak"'
Autor:
Vera Paar, Michael Haslinger, Philipp Krombholz-Reindl, Stefan Pittner, Matthias Neuner, Peter Jirak, Tobias Kolbitsch, Bernd Minnich, Falk Schrödl, Alexandra Kaser-Eichberger, Kristen Kopp, Andreas Koller, Clemens Steinwender, Michael Lichtenauer, Fabio C. Monticelli, Rainald Seitelberger, Uta C. Hoppe, Christian Dinges, Lukas J. Motloch
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Introduction: Hypertrophies of the cardiac septum are caused either by aortic valve stenosis (AVS) or by congenital hypertrophic obstructive cardiomyopathy (HOCM). As they induce cardiac remodeling, these cardiac pathologies may promote an arrhythmog
Externí odkaz:
https://doaj.org/article/78c32d47ee014a5495a47d06850ea9cb
Autor:
Lukas Fiedler, Lukas J. Motloch, Anna-Maria Dieplinger, Peter Jirak, Paruir Davtyan, Diana Gareeva, Elena Badykova, Marat Badykov, Irina Lakman, Aleksandr Agapitov, Liana Sadikova, Valentin Pavlov, Fabian Föttinger, Moritz Mirna, Kristen Kopp, Uta C. Hoppe, Rudin Pistulli, Benzhi Cai, Baofeng Yang, Naufal Zagidullin
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Introduction: While acute Coronavirus disease 2019 (COVID-19) affects the cardiovascular (CV) system according to recent data, an increased CV risk has been reported also during long-term follow-up (FU). In addition to other CV pathologies in COVID-1
Externí odkaz:
https://doaj.org/article/5e2dcd583bcc4eb4b30434008f09491a
Autor:
Elke Boxhammer, Meriem Bellamine, Istvan Szendey, Mike Foresti, Marc Bonsels, Joseph Kletzer, Peter Jirak, Albert Topf, Johannes Kraus, Lukas Fiedler, Anna-Maria Dieplinger, Uta C. Hoppe, Bernhard Strohmer, Lars Eckardt, Rudin Pistulli, Lukas J. Motloch, Robert Larbig
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 10 (2023)
IntroductionWhile in the CASTLE-AF trial, in patients with atrial fibrillation and heart failure with reduced ejection fraction, interventional therapy using pulmonary vein isolation was associated with outcome improvement, data on cavotricuspid isth
Externí odkaz:
https://doaj.org/article/e7c1f4a8bec74a46864e783660c1dc2f
Autor:
Lukas J. Motloch, Peter Jirak, Moritz Mirna, Lukas Fiedler, Paruir A. Davtyan, Irina A. Lakman, Diana F. Gareeva, Anton V. Tyurin, Ruslan M. Gumerov, Simon T. Matskeplishvili, Valentin N. Pavlov, Benzhi Cai, Kristen Kopp, Albert Topf, Uta C. Hoppe, Rudin Pistulli, Naufal S. Zagidullin
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
IntroductionCardiovascular events are common in COVID-19. While the use of anticoagulation during hospitalization has been established in current guidelines, recommendations regarding antithrombotic therapy in the post-discharge period are conflictin
Externí odkaz:
https://doaj.org/article/df0ac22d833b4b75bb342820539b4344
Autor:
Peter Jirak, Robert Larbig, Zornitsa Shomanova, Elisabeth J. Fröb, Daniel Dankl, Christian Torgersen, Nino Frank, Magdalena Mahringer, Dominyka Butkiene, Hendrik Haake, Helmut J.F. Salzer, Thomas Tschoellitsch, Michael Lichtenauer, Alexander Egle, Bernd Lamprecht, Holger Reinecke, Uta C. Hoppe, Rudin Pistulli, Lukas J. Motloch
Publikováno v:
ESC Heart Failure, Vol 8, Iss 1, Pp 37-46 (2021)
Abstract Aims COVID‐19, a respiratory viral disease causing severe pneumonia, also affects the heart and other organs. Whether its cardiac involvement is a specific feature consisting of myocarditis, or simply due to microvascular injury and system
Externí odkaz:
https://doaj.org/article/b894aa902cdb44bcb6ab51cce9a95691
Autor:
Lukas J. Motloch, Peter Jirak, Diana Gareeva, Paruir Davtyan, Ruslan Gumerov, Irina Lakman, Aleksandr Tataurov, Rustem Zulkarneev, Ildar Kabirov, Benzhi Cai, Bairas Valeev, Valentin Pavlov, Kristen Kopp, Uta C. Hoppe, Michael Lichtenauer, Lukas Fiedler, Rudin Pistulli, Naufal Zagidullin
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
AimsWhile COVID-19 affects the cardiovascular system, the potential clinical impact of cardiovascular biomarkers on predicting outcomes in COVID-19 patients is still unknown. Therefore, to investigate this issue we analyzed the prognostic potential o
Externí odkaz:
https://doaj.org/article/8e990f1e7787410caa554f9c85be0aca
Autor:
Peter Jirak, Vincent van Almsick, Dimitrios Dimitroulis, Moritz Mirna, Clemens Seelmaier, Zornitsa Shomanova, Bernhard Wernly, Dilvin Semo, Daniel Dankl, Magdalena Mahringer, Michael Lichtenauer, Uta C. Hoppe, Holger Reinecke, Rudin Pistulli, Robert Larbig, Lukas J. Motloch
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
BackgroundSevere COVID-19 pneumonia requiring intensive care treatment remains a clinical challenge to date. Dexamethasone was reported as a promising treatment option, leading to a reduction of mortality rates in severe COVID-19 disease. However, th
Externí odkaz:
https://doaj.org/article/7d2ac64ad9db47f9af6610e76906f0c2
Autor:
Peter Jirak, Zornitsa Shomanova, Robert Larbig, Daniel Dankl, Nino Frank, Clemens Seelmaier, Dominyka Butkiene, Michael Lichtenauer, Moritz Mirna, Bernhard Strohmer, Jan Sackarnd, Uta C. Hoppe, Jürgen Sindermann, Holger Reinecke, Gerrit Frommeyer, Lukas J. Motloch, Rudin Pistulli
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 8 (2021)
Aims: Thromboembolic events, including stroke, are typical complications of COVID-19. Whether arrhythmias, frequently described in severe COVID-19, are disease-specific and thus promote strokes is unclear. We investigated the occurrence of arrhythmia
Externí odkaz:
https://doaj.org/article/0316fba39378471e9e5a784d47c7ab7c
Autor:
Lukas Fiedler, Lukas J. Motloch, Peter Jirak, Ruslan Gumerov, Paruir Davtyan, Diana Gareeva, Irina Lakman, Alexandr Tataurov, Gulnaz Lasinova, Valentin Pavlov, Laurenz Hauptmann, Kristen Kopp, Uta C. Hoppe, Michael Lichtenauer, Rudin Pistulli, Anna-Maria Dieplinger, Naufal Zagidullin
Publikováno v:
Biomedicines, Vol 10, Iss 11, p 2889 (2022)
Introduction: COVID-19 survivors reveal an increased long-term risk for cardiovascular disease. Biomarkers like troponins and sST-2 improve stratification of cardiovascular risk. Nevertheless, their prognostic value for identifying long-term cardiova
Externí odkaz:
https://doaj.org/article/444015f215894f6e8dbd4d500425ac0b
Autor:
Khaled Q A Abdullah, Jana V Roedler, Juergen Vom Dahl, Istvan Szendey, Hendrik Haake, Lars Eckardt, Albert Topf, Bernhard Ohnewein, Peter Jirak, Lukas J Motloch, Bernhard Wernly, Robert Larbig
Publikováno v:
PLoS ONE, Vol 16, Iss 2, p e0247667 (2021)
BackgroundCritically ill patients with cardiogenic shock could benefit from ventricular assist device support using the Impella microaxial blood pump. However, recent studies suggested Impella not to improve outcomes. We, therefore, evaluated outcome
Externí odkaz:
https://doaj.org/article/51ada3a3557e4caa8e8da73adc07844c